Status:
COMPLETED
Efficacy Study of Dialyzed Leukocytes Extracts to Treat Paediatric Moderate Atopic Dermatitis
Lead Sponsor:
National Polytechnic Institute, Mexico
Collaborating Sponsors:
Hospital Infantil de Mexico Federico Gomez
Instituto de Oftalmología Fundación Conde de Valenciana
Conditions:
Childhood Atopic Dermatitis
Eligibility:
All Genders
2-17 years
Phase:
PHASE2
Brief Summary
Patients with atopic dermatitis treated with conventional treatment plus Dialyzed Leukocyte Extracts (DLE-oral Transferon) as adjuvant, have better clinical outcome than patients treated only with con...
Eligibility Criteria
Inclusion
- Atopic dermatitis diagnosis by Hanifin and Rajka classification
- Dermatitis severity: Moderate, according with SCORAD index.
- Patients without treatment of topical steroids or immunosuppressants in the last 3 weeks.
- Patients with "informed consent form" signed by both parents, or advisor.
- Patients 7 years old or older whom have signed the assent form
Exclusion
- Patient who were treated with topical, or systemic steroids and/or immunosuppressants and they cannot discontinue their treatment.
- Patients who lived far from the hospital and they could not go to the visits.
Key Trial Info
Start Date :
August 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2013
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT01902836
Start Date
August 1 2011
End Date
January 1 2013
Last Update
July 29 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Infantil de México, Fedérico Gómez
Mexico City, Mexico City, Mexico, 06720